Anthrax vaccine related to multiple cancers and other illnesses:

Army statistics provided to Institute of Medicine in 2001 but never published

What conditions are found much more often after anthrax vaccinations? The list is surprising, and (unsurprisingly) women are especially affected. This series of 3 tables does not give us the raw data, instead providing data that has been statistically adjusted by the army. Where does this data come from?

Benign breast lumps leading to hospitalization occurred a whopping 9 times as often after anthrax vaccinations as before. Breast and genitourinary cancer hospitalizations occurred more than 3.5 times as often. Abnormal PAP smears led to hospitalization more than 5 times as often after vaccination.

Hospitalizations for nerve damage in the arm--usually the vaccinated arm--or several damaged nerves (mononeuritis multiplex) occurred 1.6 times as often. Eyelid problems leading to hospitalization occurred more than twice as often. This is no joke. Draining, purulent eyelids appear to be a common consequence of anthrax vaccination, and the reason is obscure. Optic neuropathy leading to hospitalization occurred nearly 3 times as often after vaccination. This condition is usually autoimmune, and many cases later develop into multiple sclerosis.

Dermatophytosis is a fungal skin infection. It resulted in hospitalizations nearly 5 times as often after vaccination. Is this a consequence of impaired immunity to fungal infection?

Some illnesses made the list because they simply occur more often during deployments, like malaria, cholera and typhoid. Anthrax vaccinations are required for soldiers who deploy, but not required for other troops. Others illnesses may be miscoded. Many males have reported testicular inflammation after anthrax vaccine, which may lead to low testosterone levels, loss of interest in sex, and difficulties conceiving. (I have evaluated a number of males with this problem.) Perhaps some of these cases were miscoded as hydrocele, which is associated with fluid on the testis but is not due to acute inflammation.

Look at the second table: there are a list of cancers that caused hospitalizations more often after anthrax vaccine. Female uterine cancer hospitalizations were more than 4 times more common after vaccination. Gallbladder and bile duct cancer hospitalizations were nearly 3 times as common.

Blood clots seem to be related to vaccination. Both hospitalizations for portal vein thrombosis and "acute pulmonary heart disease" (pulmonary embolism) are more common. So are hospitalizations for varicose veins, and "injury of blood vessels of upper extremity" which may represent miscoded episodes of deep vein thrombosis.

Here are additional Tables from the Army Medical Surveillance Activity on illnesses pre and post-vaccination.

Anthrax vaccine seems to cause very unusual illnesses and patterns of symptoms that cannot be found in medical textbooks. This might be why nonspecific diagnostic codes are used more often in hospitalizations after vaccination, such as: "other disorders of stomach and duodenum," "other disorders of the respiratory system," "ill-defined descriptions of heart disease," "symptoms involving nervous and musculoskeletal," "other nonspecific abnormal findings," and "complications of medical care, not elsewhere classified." These diagnoses need to be sorted out, so we can discover precisely what kinds of complex illnesses are due to the vaccine.

It is also important to note that, overall, vaccinated soldiers did not have more hospitalizations than unvaccinated troops, or than they did prior to vaccination. Thus it appears there are specific diagnoses, or clusters or symptoms, that vaccinated troops develop at relatively high rates, which unvaccinated troops develop at much lower rates. However, because there seem to be dozens of these diagnoses, rather than just one or two, it has been harder to pin the relationships down. Compounding this difficulty is the military's failure to release hospitalization and outpatient data since 2001.

Here is the way these data were presented in the 2002 IOM report on anthrax vaccine. Each URL represents one page in the report. To get a printable pdf version, click on "printable pdf page" next to the page number:

http://books.nap.edu/openbook.php?record_id=10310&page=246

http://books.nap.edu/openbook.php?record_id=10310&page=247

http://books.nap.edu/openbook.php?record_id=10310&page=248

http://books.nap.edu/openbook.php?record_id=10310&page=249

http://books.nap.edu/openbook.php?record_id=10310&page=250

http://books.nap.edu/openbook.php?record_id=10310&page=251

An HHS-DOD "Anthrax Vaccine Expert Committee" examined 1841 VAERS reports for the government, which had been reported to FDA between 1998 and 2001. This committee found that there was one report for every 282 vaccine recipients. Again, women were disproportionately represented, reporting three times as often as would be expected if there were no gender difference. Flu-like symptoms and rashes often tended to recur with subsequent doses. The Committee's report can be found here. Over 5200 people have now filed VAERS reports for anthrax vaccine.

---

http://anthraxvaccine.blogspot.com/